Maryland Senate Votes Down Legislation To Bolster Medicaid Fraud Investigation Efforts
Main Category: Medicare / Medicaid / SCHIPAlso Included In: Litigation / Medical Malpractice
Article Date: 27 Mar 2009 - 7:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
4 (1 votes) |
The Maryland Senate on Tuesday defeated by one vote a bill that intended to step up efforts to root out fraud in the state's Medicaid program, the Baltimore Sun reports. The bill, which was similar to laws passed in almost half of the states, would have enabled Maryland officials to pursue smaller cases of fraud and collect civic penalties of up to $10,000 and triple damages. Under current law, those found guilty of fraud can be penalized only for the amount in question. In addition, the law would have allowed whistle-blowers to file lawsuits on behalf of the state.
Maryland Gov. Martin O'Malley (D) said the bill should be passed in light of the state's financial troubles and included $22 million in his budget proposal from additional collections from providers who defraud Medicaid. According to some estimates, 10% of Medicaid dollars are lost to fraud, and state officials say that since the federal government passed similar legislation in 1986, it has recouped more than $16 billion. Maryland Department of Health and Mental Hygiene Inspector General Thomas Russell said, "States that have this have been able to put taxpayer money back into the budget as a result of unscrupulous entities taking advantage of the Medicaid program."
The bill faced strong opposition from doctor, hospital and pharmaceutical industry groups, who said the changes would lead to more frivolous lawsuits and increase administrative costs for providers. According to the groups, those costs would then be shifted to patients at a time when the rising cost of health care is already a national problem. Nancy Fiedler of the Maryland Hospital Association said the measure would have made it more difficult for hospitals to retain physicians in the state and would have increased litigation costs, adding that 60% of state hospitals lost money in the last quarter of 2008. She said that her group did not believe claims that the bill would have generated meaningful savings. Jonathan Diesenhaus, an attorney representing the Pharmaceutical Research and Manufacturers of America, said, "If we're having trouble chasing Medicaid fraud ... this is not the solution," noting that the bill would "cost money and create improper incentives for prosecutors" (Smitherman, Baltimore Sun, 3/25).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/143934.php>
APA
http://www.medicalnewstoday.com/releases/143934.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




